KAYLA FERRY: Open Payments
NPI 1932968476 · SAINT CLOUD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 55 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,311 · 2025 $1,048
Food & beverage: $947Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $229 |
| Otsuka America Pharmaceutical, Inc. | 10 | $177 |
| ABBVIE INC. | 11 | $168 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, UZEDY, Auvelity.
Industry payments across FL — which companies pay providers there.
